|
Item 1.
|
(a)
|
Name of Issuer
|
F-Star Therapeutics, Inc.
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
Eddeva B920
Babraham Research Campus
Cambridge, United Kingdom CB22 3AT
|
Item 2.
|
(a)
|
Name of Person Filing
|
This statement is filed by the following entities (collectively, referred to as the “Reporting
Persons”):
Merck Ventures B.V. is a wholly owned subsidiary of Merck B.V. Merck B.V. may be deemed to have sole voting and dispositive power with respect to
the shares held by Merck Ventures B.V.
Merck Ventures B.V. is a wholly owned indirect subsidiary of Merck KGaA, a publicly traded company. Merck KGaA may be deemed to have sole voting
and dispositive power with respect to the shares held by Merck Ventures B.V.
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
The address of the principal business office for Merck Ventures B.V. is:
Gustav Mahlerplein 102, Toyo Ito Building, 20th Floor
1082 MA Amsterdam, The Netherlands
The address of the principal business office for Merck B.V. is:
Tupolevlaan 41-61
1119 NW Schiphol-Rijk, The Netherlands
The address of the principal business office for Merck KGaA is:
Frankfurter Straße 250
64293 Darmstadt, Germany
Merck Ventures B.V. is a private limited company located in the Netherlands.
Merck B.V. is a private limited company located in the Netherlands.
Merck KGaA is a German public company (Frankfurt Stock Exchange, DAX 40).
|
(d)
|
Title of Class of Securities
|
Common Stock, par value $0.0001 per share
30315R 107
|
Item 3.
|
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
|
Not applicable.
(a) Amount beneficially owned:
See Row 9 of cover page for each Reporting Person.
(b) Percent of class:
See Row 11 of cover page for each Reporting Person.
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Row 5 of cover page for each Reporting Person.
(ii) Shared power to vote or to direct the vote:
See Row 6 of cover page for each Reporting Person.
(iii) Sole power to dispose or to direct the disposition of:
See Row 7 of cover page for each Reporting Person.
(iv) Shared power to dispose or to direct the disposition of:
See Row 8 of cover page for each Reporting Person.
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the
beneficial owner of more than 5 percent of the class of securities, check the following ý.
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not applicable.
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
|
Not applicable.
|
Item 8.
|
Identification and Classification of Members of the Group.
|
Not applicable.
|
Item 9.
|
Notice of Dissolution of Group.
|
Not applicable.
Not applicable.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.